Rich People Trades
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Rich People Trades

Investing

Collaboration with DuPont Water Solutions to Test Lithium Processing Technology

by admin April 17, 2025
April 17, 2025
Collaboration with DuPont Water Solutions to Test Lithium Processing Technology

CleanTech Lithium (AIM:CTL), an innovative sustainable lithium developer in Chile, is collaborating with DuPont Water Solutions, a business unit of DuPont, to test lithium processing technology.

DuPont has developed a new nanofiltration (NF) membrane technology for high lithium recovery. This will be tested in CleanTech Lithium’s direct lithium extraction (DLE) downstream process.

The role of the NF is to remove impurities and maximise lithium recovery. DuPont’s new NF membrane element (named FilmTec LiNE-XD nanofiltration elements) is specifically designed for the lithium sector and will be tested in CTL´s next scheduled phase of post-DLE pilot plant testing. CTL is implementing NF following the eluate concentration stage which utilises industrial forward osmosis (iFO) in the concentrating of lithium and reduction of boron. CleanTech Lithium is investigating the potential of these technologies to eliminate the need for thermal evaporation (TE) and crystallisation in production of battery grade lithium carbonate, which would result in potentially significant CAPEX savings.

Click here for the full press Release

This post appeared first on investingnews.com

previous post
Universal’s new Epic Universe park set to generate $2 billion for Florida in year one
next post
Top 5 Junior Copper Stocks on the TSXV in 2025

Related Posts

Glencore Pursues Argentina Incentives for US$13.5 Billion Copper...

August 21, 2025

Productivity Commission Says Trump’s Tariffs Will “Redirect” Others...

August 7, 2025

Presenting on Emerging Growth Conference 81 Day 1...

April 16, 2025

Germany, Italy Face Pressure to Repatriate US$245 Billion...

June 25, 2025

Crypto Market Recap: CME Launches SOL Futures Contracts,...

March 19, 2025

2 Biggest Medical Device ETFs in 2025

February 18, 2025

Crypto Market Recap: Trump’s US$2 Billion Stablecoin Deal...

May 3, 2025

Skyharbour’s Partner North Shore Uranium Signs Exploration Agreement...

March 21, 2025

China’s Rare Earths Crackdown Puts MP Materials in...

November 26, 2025

Altech Batteries LimitedAcquisition of Additional Investments CERENERGY and...

February 28, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      First lady Melania Trump’s new official portrait revealed

      January 28, 2025
    • 2

      American fighters are dying in Ukraine in growing numbers. Bringing their bodies home is a complex task

      January 30, 2025
    • 3

      ECOWAS pledges to ‘keep door open’ after 3 coup-hit West African nations exit regional bloc

      January 30, 2025
    • 4

      Vale Launches Strategic Review of Thompson Nickel Operations Amid Market Challenges

      January 28, 2025
    • 5

      Europe’s busiest airport is set to get bigger, as Britain green-lights tortured Heathrow expansion project

      January 30, 2025
    • 6

      DeepSeek is giving the world a window into Chinese censorship and information control

      January 30, 2025
    • 7

      Top Altcoins to Watch in 2025: An Investor’s Guide

      January 28, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: richpeopletrades.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 richpeopletrades.com | All Rights Reserved